These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16311895)
21. Different characteristic phenotypes according to antibody in myasthenia gravis. Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384 [TBL] [Abstract][Full Text] [Related]
22. Paroxysmal supraventricular tachycardia in anti-musk Myasthenia gravis: A case report. Di Giovanni M; Battisti C; Salvatore S; Tumminelli G; Vinciguerra C; Ruocco G; Federico A J Neurol Sci; 2016 Oct; 369():250-251. PubMed ID: 27653899 [No Abstract] [Full Text] [Related]
23. Transmission of maternal muscle-specific tyrosine kinase (MuSK) to offspring: report of two cases. Murray EL; Kedar S; Vedanarayanan VV J Clin Neuromuscul Dis; 2010 Dec; 12(2):76-9. PubMed ID: 21386774 [TBL] [Abstract][Full Text] [Related]
24. Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey. Alahgholi-Hajibehzad M; Yilmaz V; Gülsen-Parman Y; Aysal F; Oflazer P; Deymeer F; Saruhan-Direskeneli G Hum Immunol; 2013 Dec; 74(12):1633-5. PubMed ID: 23993985 [TBL] [Abstract][Full Text] [Related]
25. Active management in patients with ocular manifestations of myasthenia gravis. Bentley CR; Dawson E; Lee JP Eye (Lond); 2001 Feb; 15(Pt 1):18-22. PubMed ID: 11318287 [TBL] [Abstract][Full Text] [Related]
26. [The WEBINO syndrome as presentation form of myasthenia gravis]. Fagúndez Vargas MA ; Andrés Domingo ML ; Calvo Arrabal MA Arch Soc Esp Oftalmol; 2000 Jul; 75(7):485-8. PubMed ID: 11151202 [TBL] [Abstract][Full Text] [Related]
27. [Myasthenia gravis induced by autoantibodies against MuSK]. Shigemoto K; Konishi T; Ohta M Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361 [TBL] [Abstract][Full Text] [Related]
28. AchR-positive myasthenia gravis with MRI evidence of early muscle atrophy. Zouvelou V; Rentzos M; Toulas P; Evdokimidis I J Clin Neurosci; 2012 Jun; 19(6):918-9. PubMed ID: 22341149 [TBL] [Abstract][Full Text] [Related]
30. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981 [TBL] [Abstract][Full Text] [Related]
31. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report]. Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110 [TBL] [Abstract][Full Text] [Related]
35. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis. Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100 [TBL] [Abstract][Full Text] [Related]
36. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)]. Sanadze AG; Sidnev DV; Karganov MIu Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492 [TBL] [Abstract][Full Text] [Related]
37. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis. Reddel SW; Morsch M; Phillips WD Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928 [TBL] [Abstract][Full Text] [Related]